Robert Jones 
Tekton is expanding to Houston, TX, with the addition of Lawrence D. Ginsberg, MD. Dr. Ginsberg will lead adult and pediatric psychiatry studies as a Principal Investigator from his clinic, Red Oak Psychiatry Associates. This marks Tekton’s first research location in Houston. Dr. Ginsberg has practiced psychiatry since 1985 and has served as president and … Read more
Andrew H. Martin, MD, psychiatrist and founder of Texas Family Psychiatry, will expand Tekton’s psychiatry research capabilities in San Antonio. Tekton is pleased to welcome Andrew H. Martin, MD, as a Principal Investigator at its San Antonio dedicated research center. Dr. Martin is a psychiatrist with more than 20 years of clinical experience treating children, … Read more
Tekton’s Austin, TX, team screened the first participant globally for Boehringer Ingelheim’s Phase 3 study evaluating nerandomilast for systemic sclerosis. Congratulations to Paul Pickrell, MD, and our entire Austin team on this milestone!
Pablo Mora, MD, is the lead author of two new articles published in The Lancet. The articles report Phase 2 results for zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist being studied in adults with type 2 diabetes. Across cohorts, both once-weekly subcutaneous and once-daily oral formulations produced substantial improvements in glycemic control and … Read more
Tekton’s Principal Investigators are practicing physicians whose clinical experience and established patient relationships shape how we evaluate protocols and collaborate with Sponsors and CROs from the earliest stages of a study. On Tuesday, August 4, from noon to 1 p.m. ET, Jara McDonald, MD, FAAFP, DABOM, CPI, will present during the Society for Clinical Research … Read more
A new video featuring Pablo Mora, MD, FACE, MSc, CDCES, is now available in the Novo Nordisk ScienceHub. Dr. Mora provides an overview of the Phase 2 results for investigational zenagamtide (amycretin) in adults with type 2 diabetes. The findings were recently presented at the American Diabetes Association Scientific Sessions. In the 36-week study, once-weekly … Read more
Key Information New Carlisle, Ohio site will conduct MASH trials under Ashok Devatha, MD Embedded urgent care operation provides a high-traffic clinical access point, supported by Dr. Devatha’s primary care relationships Collaboration builds on July 2025 launch of the partnership in Yukon, Oklahoma Tekton Research, a multi-specialty clinical research site organization, is expanding its partnership … Read more
Tekton Research is pleased to share that its sites are part of Allucent’s newly launched IGNITE™ Site Network, a global network of pre-qualified clinical research sites designed to support greater speed, quality, and predictability in clinical trial delivery. IGNITE brings together sites aligned around therapeutic expertise, defined execution commitments, and earlier site engagement. The network … Read more
When people think about clinical trials, one big question usually comes up: “Will I get paid?” Often, yes. Many clinical trials offer payment for your study-related time and travel. The amount depends on the study, where it takes place, and what the study asks you to do. A short study with one visit may offer … Read more
New treatments don’t move from the lab to your local pharmacy overnight. Before a medication, vaccine, device, or other medical product becomes widely available, researchers study it through a careful process. Clinical trials help doctors and scientists learn whether something works, what dose may be appropriate, and what side effects people should know about. If you’re … Read more